In the pharmaceutical field, applied nanoscience has emerged as a revolutionary frontier, offering unprecedented opportunities for drug delivery, diagnostics, and therapeutic interventions. Nanotechnology enables the manipulation of materials at the nanoscale, allowing for the design and fabrication of drug delivery systems with enhanced precision and efficacy. Nano-sized carriers, such as liposomes and nanoparticles, can encapsulate therapeutic agents, protecting them from degradation and facilitating targeted delivery to specific cells or tissues.
This precise drug targeting minimizes side effects and improves overall treatment outcomes. Additionally, nanoscale materials have proven invaluable in diagnostic applications, facilitating early disease detection through highly sensitive imaging techniques. The intersection of nanoscience and pharmaceuticals holds great promise for advancing personalized medicine, optimizing drug formulations, and addressing challenges in bioavailability. As researchers continue to explore and harness the potential of applied nanoscience, the pharmaceutical landscape stands poised for transformative advancements that can significantly impact patient care and treatment modalities.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia